Abstract
US Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
Summary
GlobalData’s “US Coronary Stents Market: Revival of Drug Eluting
Stents to Drive Growth” report is an essential source of data and
analysis on the US coronary stents market with complete coverage by
categories. The report provides market landscape, competitive landscape and
market trends information on two market categories – bare metal stents
and drug eluting stents. The report identifies the key trends shaping and
driving the dynamism in the US coronary stents market. The report also
provides insight on the prevalent competitive landscape and on the emerging
players which are expected to bring significant shift in the market standing
of the existing leaders. The report also analyses the M&A landscape with
special focus on the market participants that have been the most M&A active.
The report also provides valuable insight on the pipeline products within the
US coronary stents market.
Scope
- The report provides market size data and information on two US coronary
stents market categories – bare metal stents and drug eluting
stents.
- Annualized market revenues data from 2001 to 2008, forecast
forward for 7 years to 2015.
- Analysis and review of the key events and
milestones that will impact the future of the US coronary stents market. Each
trend independently researched to provide qualitative analysis of what the
implications on sectors are, and how are companies responding to these
trends.
- Insightful review of key industry drivers, restraints and
challenges which are likely to impact the US coronary stents market in the
long run.
- In-depth analysis of the M&A landscape with a strong emphasis
on the market players, likely to remain active in the near future.
- The
report also covers information on the leading market players, the competitive
landscape, and the leading pipeline products and technologies.
-
Comprehensive analysis of the most likely developments expected to bring a
shift to the market positions of the leading manufacturers.
- The report
is built using data and information sourced from proprietary databases,
primary and secondary research and in house analysis by GlobalData’s
team of industry experts.
Reasons to buy
- Develop business strategies by understanding the trends shaping and driving
the US coronary stents Market.
- Design and develop your product
development, marketing and sales strategies by identifying the market
categories poised for a strong growth.
- Exploit in-licensing and
out-licensing opportunities by identifying products that are most likely to
ensure a robust return.
- Identify key players best positioned to take
advantage of the emerging market opportunities by developing insight on the
prevalent and anticipated competitive landscape.
- Drive revenues by
understanding key trends, innovative products and technologies, market
segments and companies likely to impact the US coronary stents market in
future.
- Effectively plan your M&A and partnership strategies by
identifying companies with the most promising pipeline.
- Identify
emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage.
-
What’s the next being thing in the US coronary stents technology
landscape? – Identify, understand and capitalize.
| 
View Cart
